EW: Edwards Market Cap to Revenue Ratio

Symbol and logo of brand Edwards Lifesciences Corp (EW)

Edwards Lifesciences dominates the cardiology sector thanks to its unique minimally invasive valve replacement methods. The price-to-sales ratio visualizes this premium valuation, where the 9.10 level reflects the current magnitude of market expectations. Patents and an evidence-based foundation protect the issuer's position from competitive pressure, while a strategy of acquiring small startups ensures organic growth through the integration of new developments.

Edwards Lifesciences Corporation (EW): P/S Multiple from 07/04/2022 to 11/13/2026

Metric breakdowns and analytics for Edwards Lifesciences Corp (EW)

- current quotes and average value forecast:
Market Price edwards.com|EW - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Edwards Lifesciences Corp|EW - Enterprise Value
- business book valuation details:
Net Assets per Share Edwards Lifesciences|EW - Book Capitalization|Market Cap to Net Assets Ratio edwards.com|EW - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Edwards Lifesciences|EW - Long-Term Debt to Equity|Short-Term Debt to Equity Edwards Lifesciences Inc.|EW - Company Total Debt|Debt to Net Assets Ratio Edwards Lifesciences Corp|EW - Company Long-Term Debts|Short-Term Debt Edwards Lifesciences|Critical Liquidity edwards.com
- net income and valuation ratios data:
EW - Net Income|Projected Future Earnings Edwards Lifesciences|EW - P/E Multiple|Market Cap to Projected Earnings Edwards|EW - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Corp|EW - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Edwards Lifesciences|EW - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months edwards.com|EW - Earnings per share growth in current year|Projected earnings per share growth rate for next year Edwards Lifesciences
- issuer revenue and sales details:
EW - Company Sales|Company Projected Revenue Volume edwards.com|EW - P/S Multiple|Market Cap to Future Revenue Ratio Edwards Lifesciences Corp
Summary company analytics:edwards.com, EW
Signature product of Edwards Lifesciences Inc.

The P/S ratio determines the market value of one dollar of sales, allowing for an assessment of the premium paid for an asset relative to its revenue. By analyzing the divergence of the P/S from its historical average at the current value of 9.10, an investor compares the multiple with the business uniqueness of Edwards Lifesciences (EW), whose dominance in the minimally invasive valve segment justifies a premium valuation due to a lack of technological alternatives.

Competing companies

BSX - Price to Sales|P/S Multiple RMD (ResMed)|PODD: Market Cap to Revenue Ratio|Zimmer - P/S Multiple|Price-to-Revenue Coefficient CooperSurgical COO|ALGN: P/S Multiple|Market Cap to Revenue globusmedical.com|TMDX (TransMedics Group, Inc.) - P/S Multiple|P/S Multiple Alphatec Holdings|Price-to-Revenue Ratio Artivion Inc (AORT)|Price-to-Revenue Ratio ENOV (Enovis Inc.)|Integra LifeSciences - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio ESTA|Beta Bionics - P/S Multiple|Price to Sales IRADIMED Corp|Embecta Inc. (EMBC) - Price-to-Revenue Ratio|Price-to-Revenue Multiple Tandem Corp TNDM|Market Cap to Revenue AXGN|P/S Multiple si-bone.com|P/S Multiple OFIX|Price-to-Revenue Coefficient Bioventus Inc|Price-to-Revenue Ratio OrthoPediatrics KIDS|TMCI (Treace Corp) - Price-to-Sales Ratio|SRTA - Price-to-Revenue Ratio|carlsmed.com (CARL) - Market Cap to Revenue|RXST: P/S Multiple|Price to Sales ClearPoint Neuro (CLPT)|Price-to-Revenue Ratio Stereotaxis Corp|Market Cap to Revenue Ratio STIM (Neuronetics, Inc)|Market Cap to Revenue SGHT (Sight Sciences, Inc.)|Market Cap to Sales Volume OBIO|P/S Multiple ANIK (Anika Therapeutics, Inc.)|InspireMD Inc (NSPR) - Price to Sales|Jin Medical International Ltd - P/S Multiple|VANI (Vivani Medical, Inc.) - Market Cap to Revenue Ratio|XTNT (xtantmedical.com) - Market Cap to Revenue|Market Cap to Revenue n1mtc.com|MODD (Modular Medical Inc) - P/S Multiple|P/S Multiple Myomo Inc.|Price-to-Revenue Ratio Envoy Medical, Inc (COCH)|VVOS (Vivos Therapeutics Inc) - Market Capitalization-to-Revenue Ratio|P/S Multiple NVNO (enVVeno Medical)|SINT: Market Cap to Revenue Ratio|TNON - Price-to-Revenue Ratio|Price-to-Revenue Coefficient ReWalk Robotics LFWD|AMIX (autonomix.com) - Market Cap to Revenue|INVO Fertility Corp - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Bone Biologics|Price-to-Revenue Ratio AXNX|P/S Multiple BIOL|Price-to-Revenue Coefficient dynatronics.com|P/S Multiple FNA (Paragon 28)|INVO (INVO Bioscience Inc.) - Price-to-Sales Ratio